United States Brain Health Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The united states brain health supplements market size is projected to be USD 3.52 billion in 2025, USD 3.88 billion in 2026, and reach USD 6.32 billion by 2031, growing at a CAGR of 10.25% from 2026 to 2031. This report is Segmented by Product Type (Natural Molecules, Herbal Extracts, Vitamins and Minerals), Dosage Form (Capsules, Tablets, Softgels, Gummies, and Others), Application (Memory Enhancement, Focus, Stress and Anxiety, Sleep and Recovery, and Others), and Distribution Channel (Pharmacies, Online, Supermarkets, and Others). The Market Forecasts are Provided in Terms of Value (USD).

United States Brain Health Supplements Market Trends and Insights

Rising Mental Health and Cognitive Self-Care Awareness Among US Consumers

Mental health moved further into the wellness mainstream in 2025, and that shift continues to lift the United States brain health supplements market because consumers increasingly treat cognitive support as part of daily self-care rather than occasional intervention. Among women consumers, 65% actively sought products for mental well-being in 2025, and 94% of consumers said mental health was crucial to overall wellness, which broadens demand well beyond older memory-focused buyers. Product activity followed that behavioral change, with 190 launches carrying brain health claims and 177 launches carrying cognitive sharpness positioning in 2024. This pattern matters because it widens the age profile of the category and pulls younger adults into the United States brain health supplements market for performance, clarity, and resilience rather than decline management alone. It also means brands can no longer rely on senior-focused messaging only, since the category now sits closer to everyday wellness routines than to occasional cognitive concern.

Clean-Label Botanical and Nootropic Preference in the US Premium Wellness Sector

Preference for clean-label products is strengthening product selection in the United States brain health supplements market, especially in premium channels where consumers are checking ingredient quality, origin, and testing standards more closely. Brands such as Mind Lab Pro, Thorne, and Pure Encapsulations have benefited from this shift by leaning on transparent formulas, standardized extracts, and third-party testing rather than broad lifestyle positioning alone. The effect is not only demand growth, because clean-label expectations also create a higher operating bar for smaller brands that want premium pricing without comparable proof. As a result, the brain health supplements industry is seeing more investment move toward validation, certification, and formulation discipline in order to defend premium shelf position.

Efficacy Skepticism and Dose Standardization Gaps Across Key Active Ingredients

Efficacy skepticism remains one of the clearest restraints on the United States brain health supplements market because consumers and regulators are questioning whether marketed formulas reflect doses and outcomes seen in human research. Harvard Health noted that the evidence gap remains meaningful across much of the category, and the COSMOS multivitamin study was highlighted as one of the few controlled trials showing reliable episodic memory benefits, with an effect comparable to slowing cognitive aging by 2 years in adults aged 60 and older. Sales performance also shows where skepticism is surfacing, with phosphatidylserine down 23.5% and ginkgo biloba down 12.1% in U.S. cognitive supplement sales through December 2024. Those declines suggest that legacy ingredient familiarity is not enough when consumers cannot connect product claims with strong finished-product evidence. Brands that are clearer on dose, testing, and expected outcomes are therefore better placed to gain trust in the United States brain health supplements market than those relying on broad reputation alone.

Other drivers and restraints analyzed in the detailed report include:

• Rising Stress, Anxiety, and Sleep-Led Cognitive Complaints in High-Pressure US Urban Centers
• Aging US Baby Boomer Demographic Seeking Preventive Memory Maintenance
• Strict FDA and FTC Regulatory Scrutiny on Cognitive Structure-Function Claims

Segment Analysis

Herbal extracts led the United States brain health supplements market with 43.31% of the United States brain health supplements market share in 2025, making them the core product group in the category. That leadership reflects continued consumer interest in plant-derived cognitive support and in familiar herbal names such as bacopa monnieri, ginkgo biloba, ashwagandha, and lion’s mane mushroom. The segment still contains visible internal rotation, since ginkgo biloba sales declined 12.1% through December 2024 while mushroom-based cognitive ingredients posted meaningful gains, showing that buyers are not treating botanical products as interchangeable. This keeps herbal extracts important to the United States brain health supplements market, but it also raises the need for better proof, clearer positioning, and stronger differentiation within the botanical set.

Vitamins and minerals is projected to be the fastest-growing product type, with United States brain health supplements market size for this segment expected to expand at a 12.38% CAGR between 2026 and 2031. Momentum here is being driven by renewed demand for B-vitamin complexes, magnesium threonate, and longevity-linked ingredients such as NAD+ precursors. In tracked U.S. sales through December 2024, vitamin B12 rose 720% and vitamin B3 rose 609%, while NAD+ search volume at The Vitamin Shoppe increased 500% in 2025, which shows how strongly the category is benefiting from longevity and energy messaging. Harvard’s coverage of the COSMOS multivitamin findings also gives this group a more credible evidence point than many other ingredient classes have enjoyed in the past. Natural molecules such as omega-3 fatty acids, phosphatidylserine, and citicoline still occupy a premium layer within the broader product set, especially among practitioner-oriented brands that sell credibility as much as formulation complexity.

Softgels is the fastest-growing dosage form in the United States brain health supplements market, and the segment is forecast to rise at a 13.52% CAGR through 2031. Demand is improving because softgels fit well with lipid-based cognitive ingredients, support a more premium user experience, and appeal to consumers who are paying closer attention to how a product is delivered, not only what appears on the label. The format also fits older consumers well because it is generally perceived as easier to swallow than harder solid forms. This gives softgels a strong role in the United States brain health supplements market as brands try to connect efficacy messaging with convenient daily use.

Capsules remained the leading dosage form and accounted for 36.24% of the United States brain health supplements market size in 2025. Their lead came from manufacturing efficiency, consumer familiarity, and their ability to carry multi-ingredient nootropic stacks without major format constraints. At the same time, format diversification is becoming more visible, with searches for creatine gummies rising 1,300% at The Vitamin Shoppe in 2025 and liquid vitamin sales there climbing 50%, which shows that buyers are increasingly willing to move beyond the capsule default. Tablets and powders still serve practical roles through pharmacy, mass retail, and flexible dosing use cases, while liquids and shots are gaining ground in premium direct-to-consumer settings. BEVIMI’s May 2026 launch of Uno Protect, a patent-pending liquid formulation with 10 clinically studied actives, shows how newer delivery formats are being used to reposition the United States brain health supplements market beyond traditional oral routines.

Complete Report Scope:

• By Product Type
  • Natural Molecules
  • Herbal Extracts
  • Vitamins and Minerals
• By Dosage Form
  • Capsules
  • Tablets
  • Softgels
  • Gummies
  • Powders
  • Liquids and Shots
  • Other Dosage Forms
• By Application
  • Memory Enhancement
  • Attention and Focus
  • Stress and Anxiety
  • Sleep and Recovery
  • Depression and Mood
  • Other Applications
• By Distribution Channel
  • Pharmacies and Drug Stores
  • Online
  • Supermarkets and Hypermarkets
  • Other Distribution Channels

List of Companies Covered in this Report:

• Alternascript
• BrainMD
• Doctor's Best
• HVMN (Health Via Modern Nutrition Inc.)
• Jarrow Formulas
• Life Extension
• Liquid Health, Inc.
• Mind Lab Pro (Opti-Nutra)
• Natural Factors USA
• Nature Made (Pharmavite)
• Nature's Bounty
• Nestle
• Neurohacker Collective
• NOW Foods
• Onnit Labs, Inc.
• Pure Encapsulations
• Quincy Bioscience
• Reckitt Benckiser Group
• Solgar
• Thorne

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support